Session 5 (cont'd) & 6: APLC Business Meeting5th Nov 2023 Change to APLC Constitution and appointment of key positions within the EXCO, future plans for 2024 and closing remarks for...
Session 5: APLC Working Group Updates and Plans5th Nov 2023 AML Working Group: Different leads were appointed to look into several areas of focus such as TP53 mutation in AML or AML...
Session 4: Working Group Breakouts (AML) 4th Nov 2023 Industry Presentations: Industry partners took to the stage or played a pre-recording to share on the drug pipeline and took...
Session 3 & 4: Plenary AML and Working Group Session & Industry Engagement Session4th Nov 2023 Plenary AML Lecture: Prof Andrew Wei briefly reviewed the 2022 WHO and ELN classifications of AML and highlighted some of...
Session 2: Plenary CLL Session4th Nov 2023 Plenary CLL Lecture: This segment of the APLC Summit Meeting features a plenary lecture by Prof Paolo Lugia on the most...
Session 1: Plenary ALL and Working Group Session 4th Nov 2023 Welcome and Introduction: The speakers welcome the delegates to the first Asia Pacific Leukemia Consortium Summit meeting in...